Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 9 | 2024 | 514 | 3.610 |
Why?
|
| Monitoring, Intraoperative | 3 | 2024 | 115 | 1.470 |
Why?
|
| Analgesia | 2 | 2022 | 63 | 1.430 |
Why?
|
| Echocardiography, Transesophageal | 6 | 2024 | 362 | 1.390 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 428 | 1.140 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 342 | 1.120 |
Why?
|
| Postoperative Complications | 7 | 2024 | 2540 | 1.020 |
Why?
|
| Hypotension | 2 | 2017 | 76 | 0.890 |
Why?
|
| Vascular Resistance | 1 | 2024 | 104 | 0.880 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2024 | 217 | 0.800 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 394 | 0.800 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2022 | 282 | 0.780 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2022 | 14 | 0.780 |
Why?
|
| Coronary Artery Bypass | 3 | 2022 | 252 | 0.770 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 167 | 0.720 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 121 | 0.710 |
Why?
|
| Kidney Diseases | 2 | 2022 | 325 | 0.700 |
Why?
|
| Morphine | 1 | 2021 | 130 | 0.670 |
Why?
|
| Tissue Donors | 1 | 2024 | 542 | 0.660 |
Why?
|
| Medicine | 1 | 2021 | 99 | 0.630 |
Why?
|
| Hospital Rapid Response Team | 1 | 2019 | 28 | 0.620 |
Why?
|
| Kidney | 1 | 2024 | 1156 | 0.610 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 365 | 0.610 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 388 | 0.610 |
Why?
|
| Marriage | 1 | 2019 | 25 | 0.600 |
Why?
|
| Mitral Valve | 4 | 2021 | 279 | 0.580 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2019 | 42 | 0.570 |
Why?
|
| Wireless Technology | 1 | 2018 | 23 | 0.560 |
Why?
|
| Heart Transplantation | 1 | 2024 | 812 | 0.550 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 148 | 0.540 |
Why?
|
| Humans | 36 | 2024 | 95971 | 0.540 |
Why?
|
| Cystectomy | 1 | 2018 | 114 | 0.530 |
Why?
|
| Myocardium | 2 | 2022 | 596 | 0.530 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 93 | 0.530 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 22 | 0.520 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 898 | 0.520 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 512 | 0.510 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1201 | 0.470 |
Why?
|
| Mitochondria | 1 | 2019 | 623 | 0.460 |
Why?
|
| Endoscopy | 2 | 2022 | 374 | 0.420 |
Why?
|
| Aortic Valve | 4 | 2022 | 273 | 0.420 |
Why?
|
| Angiotensins | 1 | 2013 | 5 | 0.410 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 395 | 0.400 |
Why?
|
| Graft Rejection | 1 | 2018 | 1128 | 0.390 |
Why?
|
| Heparin | 1 | 2013 | 187 | 0.380 |
Why?
|
| Lung Transplantation | 1 | 2017 | 367 | 0.370 |
Why?
|
| Elective Surgical Procedures | 1 | 2013 | 156 | 0.360 |
Why?
|
| Preoperative Care | 1 | 2013 | 415 | 0.340 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 105 | 0.330 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 111 | 0.330 |
Why?
|
| Robotics | 1 | 2011 | 273 | 0.290 |
Why?
|
| Prospective Studies | 4 | 2024 | 4663 | 0.280 |
Why?
|
| Creatinine | 2 | 2022 | 299 | 0.260 |
Why?
|
| Middle Aged | 12 | 2024 | 28255 | 0.260 |
Why?
|
| Treatment Outcome | 4 | 2022 | 9092 | 0.250 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2013 | 209 | 0.240 |
Why?
|
| Aged | 8 | 2024 | 20877 | 0.240 |
Why?
|
| Blood Transfusion | 2 | 2019 | 182 | 0.220 |
Why?
|
| Death | 1 | 2024 | 97 | 0.200 |
Why?
|
| Organ Preservation | 1 | 2024 | 131 | 0.200 |
Why?
|
| Morphine Derivatives | 1 | 2022 | 8 | 0.200 |
Why?
|
| Brain Death | 1 | 2024 | 88 | 0.200 |
Why?
|
| Female | 10 | 2024 | 49938 | 0.190 |
Why?
|
| Heart Arrest, Induced | 1 | 2022 | 30 | 0.190 |
Why?
|
| Male | 13 | 2024 | 45735 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2024 | 819 | 0.190 |
Why?
|
| Portal Vein | 1 | 2022 | 122 | 0.180 |
Why?
|
| Injections, Spinal | 1 | 2021 | 48 | 0.180 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 7205 | 0.180 |
Why?
|
| Length of Stay | 2 | 2018 | 823 | 0.180 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2012 | 197 | 0.180 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 377 | 0.180 |
Why?
|
| Aorta | 1 | 2022 | 294 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1231 | 0.170 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 54 | 0.170 |
Why?
|
| Myxoma | 1 | 2020 | 31 | 0.160 |
Why?
|
| Embolism | 1 | 2020 | 34 | 0.160 |
Why?
|
| Arachnodactyly | 1 | 2020 | 2 | 0.160 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 11 | 0.160 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 30 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 65 | 0.160 |
Why?
|
| Stroke Volume | 1 | 2022 | 531 | 0.160 |
Why?
|
| Biomarkers | 2 | 2019 | 1933 | 0.150 |
Why?
|
| Craniosynostoses | 1 | 2020 | 73 | 0.150 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1794 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2022 | 221 | 0.150 |
Why?
|
| Glycation End Products, Advanced | 1 | 2018 | 12 | 0.150 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2018 | 21 | 0.150 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2018 | 24 | 0.150 |
Why?
|
| Retrospective Studies | 2 | 2024 | 10190 | 0.150 |
Why?
|
| Risk Factors | 3 | 2022 | 5949 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 207 | 0.140 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2018 | 47 | 0.130 |
Why?
|
| Spleen | 1 | 2018 | 439 | 0.130 |
Why?
|
| Echocardiography | 1 | 2022 | 1004 | 0.130 |
Why?
|
| Electroencephalography | 1 | 2022 | 824 | 0.130 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2018 | 92 | 0.130 |
Why?
|
| Heart Failure, Diastolic | 1 | 2016 | 2 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 206 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 380 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2018 | 397 | 0.130 |
Why?
|
| Ambulatory Care | 1 | 2018 | 200 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2018 | 290 | 0.120 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 663 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 639 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2018 | 314 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2016 | 189 | 0.110 |
Why?
|
| Hypoxia | 1 | 2018 | 683 | 0.100 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 56 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 95 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1069 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 810 | 0.100 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2013 | 143 | 0.090 |
Why?
|
| Respiration, Artificial | 2 | 2011 | 424 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 61 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 146 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 148 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 99 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 107 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 363 | 0.090 |
Why?
|
| Hypertension | 1 | 2016 | 776 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2012 | 201 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2012 | 382 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2011 | 166 | 0.080 |
Why?
|
| Adult | 4 | 2013 | 28637 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2012 | 484 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2011 | 481 | 0.070 |
Why?
|
| Acute Disease | 1 | 2011 | 871 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2011 | 363 | 0.070 |
Why?
|
| Logistic Models | 1 | 2011 | 1263 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2011 | 780 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2011 | 460 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2018 | 3587 | 0.070 |
Why?
|
| Insulin | 1 | 2012 | 1190 | 0.070 |
Why?
|
| Chicago | 1 | 2011 | 1504 | 0.060 |
Why?
|
| Mice | 1 | 2018 | 12559 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2011 | 2478 | 0.050 |
Why?
|
| Pregnancy | 1 | 2011 | 3241 | 0.050 |
Why?
|
| Time Factors | 1 | 2011 | 5577 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2022 | 83 | 0.050 |
Why?
|
| Stroke | 1 | 2011 | 1086 | 0.050 |
Why?
|
| Young Adult | 1 | 2013 | 7001 | 0.040 |
Why?
|
| Animals | 1 | 2018 | 28924 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 171 | 0.040 |
Why?
|
| Heart Atria | 1 | 2020 | 290 | 0.040 |
Why?
|
| Counterpulsation | 1 | 2018 | 21 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 679 | 0.030 |
Why?
|
| Vitrectomy | 1 | 2016 | 49 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 3093 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2013 | 136 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 193 | 0.020 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 121 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2012 | 88 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 76 | 0.020 |
Why?
|
| Cardiology | 1 | 2013 | 130 | 0.020 |
Why?
|
| Ischemia | 1 | 2013 | 257 | 0.020 |
Why?
|
| Cardioplegic Solutions | 1 | 2011 | 17 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 2011 | 18 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 34 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2012 | 133 | 0.020 |
Why?
|
| Anesthesiology | 1 | 2013 | 169 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 283 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2011 | 162 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 261 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 343 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2013 | 289 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 239 | 0.020 |
Why?
|
| Anesthesia | 1 | 2011 | 175 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 522 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1805 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 713 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 448 | 0.020 |
Why?
|